Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08QZH
|
|||
| Drug Name |
Anti-HER2 CAR-T
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 1/2 | [1] | |
| Gastric adenocarcinoma [ICD-11: 2B72; ICD-9: 151] | Phase 1/2 | [1] | ||
| Glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [1] | ||
| Lung cancer [ICD-11: 2C25.0; ICD-9: 162] | Phase 1/2 | [1] | ||
| Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 1/2 | [1] | ||
| Pancreatic cancer [ICD-11: 2C10] | Phase 1/2 | [1] | ||
| Company |
Zhi Yang
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02713984) A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.